42 min listen
First Rounders: Christoph Lengauer
FromFirst Rounders
ratings:
Length:
77 minutes
Released:
Nov 1, 2018
Format:
Podcast episode
Description
Christoph Lengauer is a venture partner at Third Rock Ventures, the president of Celsius Therapeutics, and executive vice president at Blueprint Medicines. His conversation with Nature Biotechnology covers growing up in Austria, why he nearly gave up research for a career helping settle refugees, and his role in the Henrietta Lacks story. Hosted on Acast. See acast.com/privacy for more information.
Released:
Nov 1, 2018
Format:
Podcast episode
Titles in the series (61)
First Rounder: Henri Termeer: Nature Biotechnology podcast by First Rounders